Ƶ

No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No More

— News, features, and commentary about cancer-related issues

Ƶ MedicalToday
Onco Break over a computer rendering of a cancer cell.

, as the FDA faces multiple challenges in its oversight of COVID-19-related production disruptions at foreign manufacturing facilities. (BioSpace)

A filed in Florida alleges that Intuitive Surgical's da Vinci robotic surgical system burned and tore the small intestine of a patient during an operation for colon cancer. (NBC News)

An international collaboration of experts has published the first clinical guideline for . (eClinicalMedicine)

High rates of continue to increase the cost of care and the risk of complications. (UTHealth Houston, Annals of Surgical Oncology)

Many people remain unaware of the hazards of , and few people take precautions against sun exposure during outdoor activities in the winter. (American Academy of Dermatology)

Gilead Sciences announced in acute myeloid leukemia because of increased mortality and said the FDA put a clinical hold on all studies of the drug in myelodysplastic syndrome.

The National Comprehensive Cancer Network published its first , the most common type of solid tumor in children aside from brain tumors.

Treating lung cancer with , and they should receive early intervention with antibiotics, according to a retrospective study from China. (Malignancy Spectrum)

An experimental passed an early clinical test, becoming the first drug in the class to demonstrate safety and efficacy in a phase I study. (Vall D'Hebron Institute of Oncology)

Why a person with leukemia decided to stop being . (Time)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined Ƶ in 2007.